New refereed preprint: BashTheBug Philip Fowler, 31st March 202231st March 2022 BashTheBug is a citizen science project hosted on the Zooniverse platform that we launched in April 2017 and asked volunteers to help us assess how well 20,637 clinical samples of M. tuberculosis grow on one of 13 different antibiotics. To help engage with the volunteers it has its own blog, that has grown into the Modernising Medical Microbiology unit public engagement blog — see here. Our first BashTheBug manuscript has just been made available as a refereed preprint — it it we show that the crowd of volunteers can reproducibly and accurately measure minimum inhibitory concentrations of antituberculars. Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related antimicrobial resistance citizen science clinical microbiology tuberculosis
antimicrobial resistance New preprint: using genetics to analyse ESBL infections in a neonatal ICU ward 7th July 20267th July 2026 In this preprint, Melody Parker as part of her DPhil, has analysed a series of… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New paper: Quantitative drug susceptibility testing for M. tuberculosis using unassembled sequencing data and machine learning 14th August 202414th August 2024 This is the last paper from the initial set of CRyPTIC publications following the project’s… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
Gr-ADI consortium announced 22nd January 2026 Pleased and excited to be a small part of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI)… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More